Dr. Blackman brings his singular experience as co-founder of Day One Biopharmaceuticals and a physician-scientist in pediatric neuro-oncology to the PBTF’s pediatric brain tumor communityBOSTON, Jan.
J.P. Morgan analyst James Gordon maintained a Sell rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of £14.40.
UBS analyst Jo Walton maintained a Hold rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of p1,580.00. The ...
ShareThe year 2024 etched an indelible mark on Nigeria’s economic history as over 20 highprofile multinational corporations, including Unilever Nigeria Plc, Procter & Gamble, GlaxoSmithKline Consumer ...
Zentalis Pharmaceuticals, Inc.’s ZNTL share price has dipped by 21.25%, which has investors questioning if this is right time ...
Three recent big-ticket M&A deals have raised expectations the global biotech sector is recovering from its two-year slump.
LONDON - GlaxoSmithKline PLC (LSE/NYSE: NYSE:GSK) announced today that the European Medicines Agency (EMA) has begun ...
Innovative therapies revive a once-undruggable mitochondrial aging regulator through a revolutionary enzyme activation ...
Medicare has announced 15 new drugs up for price negotiations, set to begin in the next several months with top drugmakers, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback